Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for T-helper 1 type immune response (biogroup)
Most Correlated Studies
- L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
- L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
- L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
- L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Most Relevant Literature
- Prevalence of atopy in children with type 1 diabetes mellitus, hepatitis B virus carriers, and healt…
- Midazolam suppresses maturation of murine dendritic cells and priming of lipopolysaccharide-induced …
- Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat…
- T cell augments the antitumor activity of tumor-targeting Salmonella.
- Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination.
Most Relevant Clinical Trials
- Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patient…
- Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From…
- The Significance of Release of T-follicular Helper and T-follicular Regulatory Cells in Autoimmune H…
- Immune Responses With Reduxium
- T Helper Cytokines in End Stage Colorectal Cancers
